Quadrature Capital’s Annovis Bio ANVS Stock Holding History

Quadrature Capital’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$169K	Buy	+90,884	New	+$177K	﹤0.01%	1388

Other funds holding ANVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return

Sherry Group Mountain Home, Arkansas $102M AUM

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return

Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

Quadrature Capital's ANVS Position: Q2 2026 in Review

Quadrature Capital opened a new position in Annovis Bio (ANVS) in Q2 2026: 90,884 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #1388 among its holdings.

25 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Quadrature Capital held 90,884 shares of Annovis Bio worth $169K as of Q2 2026.
Annovis Bio was a new Quadrature Capital position in Q2 2026.
Annovis Bio made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1388 holding.
25 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.